Search results
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 4 days agoThey are also testing the cancer vaccine in patients with lung cancer. So, is Moderna stock now a...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 4 days agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
News Highlights: Top Company News of the Day - Thursday at 9 AM ET
Morningstar· 4 days agoShares ticked up premarket as the company says it plans to return $9 billion to shareholders through dividends and stock buybacks in 2024. For the first time since before the onset of the < ...
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Digital Journal· 4 days agoReports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula ...
The CDC Took Out 148 Pages of Essential Information
Mercola· 4 days agoPeople who receive a COVID-19 shot are at increased risk of myocarditis, or inflammation of the heart muscle,1 and pericarditis, which is inflammation of ...
Shhh! 3 Secret Pharma Stocks Flying Below Wall Street's Radar
InvestorPlace· 3 days agoPharma stocks and massive potential go hand in hand. With devastating diseases like cancer, diabetes...
Mission Wealth Management LP Acquires New Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 1 day agoThe fund bought 2,063 shares of the company’s stock, valued at approximately $205,000. Allworth Financial LP increased its position in Moderna by 6.5% in ...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline
Guru Focus· 4 days agoOn May 2, 2024, Moderna Inc (MRNA, Financial) released its 8-K filing, disclosing a challenging first quarter with total revenues of $167 million, a stark decline from $1.9 ...
Royal Bank of Canada Increases Moderna (NASDAQ:MRNA) Price Target to $135.00
ETF DAILY NEWS· 1 day agoRoyal Bank of Canada’s target price would indicate a potential upside of 8.00% from the stock’s previous close. Canaccord Genuity Group boosted their price ...
mRNA Is Promising A Breakthrough In Fighting Cancer
Benzinga via AOL· 7 days agoWhen it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA...RNA, or mRNA, a genetic material we...